Sonia I. Skarlatos

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure

Emerson C. Perin, James T. Willerson, Carl J. Pepine et al. · JAMA · 2012 · 454 citations · Full text

Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction

Jay H. Traverse, Timothy D. Henry, Carl J. Pepine et al. · JAMA · 2012 · 386 citations · Full text

Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions

Santica M. Marcovina, Marlys L. Koschinsky, John J. Albers et al. · Clinical Chemistry · 2003 · 280 citations · Full text

Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus

Peter Libby, David M. Nathan, Kristin Abraham et al. · Circulation · 2005 · 266 citations

Metabolic Syndrome, Type 1, Diabetes Management +9

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

Jay H. Traverse, Timothy D. Henry, Douglas Vaughn et al. · American Heart Journal · 2009 · 77 citations · Full text

Thrombosis, Cell Therapy, Bone Marrow Failure +9